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The authors investigated the relation between ionizing radiation and lymphoma mortality in 2 cohorts: 1) 20,940
men in the Life Span Study, a study of Japanese atomic bomb survivors who were aged 15–64 years at the time of
the bombings of Hiroshima and Nagasaki, and 2) 15,264 male nuclear weapons workers who were hired at the
Savannah River Site in South Carolina between 1950 and 1986. Radiation dose-mortality trends were evaluated
for all malignant lymphomas and for non-Hodgkin’s lymphoma. Positive associations between lymphoma mortality
and radiation dose under a 5-year lag assumption were observed in both cohorts (excess relative rates per sievert
were 0.79 (90% confidence interval: 0.10, 1.88) and 6.99 (90% confidence interval: 0.96, 18.39), respectively).
Exclusion of deaths due to Hodgkin’s disease led to small changes in the estimates of association. In each cohort,
evidence of a dose-response association was primarily observed more than 35 years after irradiation. These
findings suggest a protracted induction and latency period for radiation-induced lymphoma mortality.
lymphoma; mortality; nuclear weapons; radiation, ionizing
Abbreviations: CI, confidence interval; ERR, excess relative rate; ICD, International Classification of Diseases; LRT, likelihood
ratio test; LSS, Life Span Study; ND, not determined; NHL, non-Hodgkin’s lymphoma; SRS, Savannah River Site.
Ionizing radiation has been considered as a cause of lym-
phoma by a number of investigators. In a review of this
literature, Boice (1) concluded that the evidence of associ-
ation between ionizing radiation and non-Hodgkin’s lym-
phoma (NHL) is extremely weak and that there is no
evidence of association between radiation and Hodgkin’s
disease. The United Nations Scientific Committee on the
Effects of Atomic Radiation noted that studies of NHL fol-
lowing external exposure to ionizing radiation have yielded
mixed results and concluded that overall there is little evi-
dence of an association between NHL and external exposure
to ionizing radiation (2). Ron (3) reached a similar conclu-
sion, noting that evidence of association between radiation
and NHL has been inconsistent and Hodgkin’s disease has
rarely been related to radiation exposure; and Melbye and
Trichopoulos (4) stated that there is no evidence that ioniz-
ing radiation causes NHL. However, this conclusion is not
universally shared. Hartge et al. argued that the evidence
suggests that ionizing radiation probably causes lymphoma
(5) and observed that high doses of ionizing radiation appear
to be associated with lymphoma risk in some studies of
radiotherapy (6).
Lack of a consistent association between ionizing radia-
tion and lymphoma could mean that there is no causal re-
lation or that a causal relation is obscured by bias or
deficiencies in exposure measurement, case classification,
duration of follow-up, or some combination of these factors.
Given that lymphoma is often an indolent disease, long-term
studies of radiation-exposed populations may be needed to
observe an effect. The development of nuclear weapons in
the early 1940s led to 2 types of epidemiologic studies that
can now provide evidence regarding the radiation-
lymphoma association: studies based on follow-up of work-
ers exposed to ionizing radiation during nuclear weapons
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production and studies based on follow-up of people ex-
posed to ionizing radiation from the use of nuclear weapons.
Most prominent among the latter is the Life Span Study
(LSS), a study of Japanese survivors of the atomic bombings
of Hiroshima and Nagasaki. Radiation risk estimates from
studies of nuclear workers are often compared with esti-
mates from the LSS in order to evaluate the consistency of
risk estimates in a population that includes people exposed
to acute high doses with estimates from populations that are
chronically exposed to low doses (7–9).
We examined the association between ionizing radiation
and lymphoma mortality in a US occupational cohort and in
a sample of LSS atomic bomb survivors and compared find-
ings from the 2 populations. Follow-up of each cohort com-
menced in 1950 and spanned approximately 5 decades. To
the extent possible, we conducted these analyses as parallel
analyses employing comparable methods. We focused, in
particular, on variation in the associations between radiation
dose and lymphoma mortality by time since exposure.
MATERIALS AND METHODS
The LSS cohort includes 86,611 people who were alive at
the time of the 1950 Japanese census, reported being in
Hiroshima or Nagasaki at the time of the bombings (August
1945), and had dose estimates based on the DS02 dosimetry
system (10). Follow-up for ascertainment of vital status and
cause-of-death information started on October 1, 1950, and
continued until December 31, 2000.
The Savannah River Site (SRS) was constructed near
Aiken, South Carolina, in 1950 as a facility to produce
materials for the US nuclear weapons program. A cohort
of 18,883 workers who were hired at the SRS prior to
1987, who worked there for at least 90 days, who were
not known to have been employed at another US Depart-
ment of Energy facility, and who had complete information
on name, Social Security number, sex, date of birth, and date
of hire was enumerated (11). Vital status and cause-of-death
information were ascertained through December 31, 2002.
Cohort restrictions for comparability
Since over 95% of the collective dose at SRS was in-
curred by males, there was little ability to estimate risk
due to radiation exposure among female SRS workers. We
therefore restricted the analyses to males in both cohorts.
Since the youngest age at hire at SRS was 15 years and most
SRS workers terminated their employment by age 65 years,
LSS analyses were restricted to people who were aged 15–
64 years at the time of the bombings. This resulted in a co-
hort of 15,264 male SRS workers and a cohort of 20,940
male LSS subjects who were aged 15–64 years at the time of
the bombings.
Dosimetry data
For the LSS, we used DS02 revised colon dose estimates
adjusted for dosimetry errors, with shielded kerma estimates
above 4 Gy truncated to 4 Gy (12). For consistency with
analyses of the SRS cohort, dose estimates calculated as the
sum of the c-radiation dose plus 10 times the neutron dose
are expressed in sieverts; some recent reports on LSS ana-
lyses refer to this quantity as the weighted dose in grays (13,
14). Interactions between radiation and lymphocytes may
occur in the lymphatic or circulatory system at a variety
of anatomic sites; the choice of target organ for dose esti-
mation may depend on the characteristics of the lymphoma,
including anatomic location (15, 16). The colon dose has
been taken as a representative dose to the organs involved at
a variety of anatomic locations, similar to the approach
employed in prior analyses of solid cancers (17). The colon
dose estimate has been used by previous investigators as an
estimate comparable to the quantity estimated by the radi-
ation dosimeters worn by nuclear industry workers (i.e., the
‘‘deep dose’’).
For SRS workers, the exposure of interest was defined as
cumulative whole-body radiation dose equivalent from ex-
ternal sources and tritium received during employment at
the site, expressed in sieverts; neutron doses were multiplied
by a factor of 10. Personal radiation monitoring data were
available for the period 1950–1999. Whole-body doses were
estimated for work-years with missing dose data using dose
estimates from adjacent time periods and average values for
similar workers; estimated annual doses constituted 4% of
employment years for male workers (18).
Outcome definitions
In the LSS, underlying cause of death was coded accord-
ing to the International Classification of Diseases, Ninth
Revision (ICD-9), which was issued in 1977. In the SRS
study, underlying cause of death was coded according to the
Eighth Revision of the ICD (ICD-8) for deaths occurring
prior to 1979 and according to the ICD revision in effect at
the time of death for deaths occurring in 1979 or later. (The
Tenth Revision of the ICD (ICD-10) was issued in 1992.)
As in prior analyses (17, 19), we examined the broad
category of malignant lymphoma (ICD-8 and ICD-9 codes
200–202; ICD-10 codes C81–C85). In addition, we exam-
ined the subcategory of NHL (ICD-8 and ICD-9 codes 200
and 202; ICD-10 codes C82–C85). There were too few
deaths due to Hodgkin’s disease to support separate analyses
of that outcome in these cohorts.
Statistical methods
Poisson regression methods were used. The analytical
data file for the LSS cohort consisted of a tabulation of
person-time and numbers of deaths by city, age at exposure
(in 5-year intervals), attained age (in 5-year intervals), cal-
endar time (1950–1952, 1953–1955, and then 5-year inter-
vals up to 1995, 1996–1997, and 1998–2000), and dose
(<0.005, 0.005–<0.02, 0.02–<0.04, 0.04–<0.06, 0.06–
<0.08, 0.08–<0.1, 0.1–<0.125, 0.125–<0.150, 0.150–
<0.175, 0.175–<0.2, 0.2–<0.25, 0.25–<0.3, 0.3–<0.5,
0.5–<0.75, 0.75–<1, 1–<1.25, 1.25–<1.5, 1.5–<1.75,
1.75–<2, 2–<2.5, 2.5–<3, and 3 Sv). The analytical data
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file for the SRS cohort consisted of a tabulation of person-
time and events by attained age (in 5-year intervals), race
(black vs. other), year of birth (before 1915, 1915–1924,
1925–1929, 1930–1934, 1935–1949, or 1950 or later), pay
code (paid monthly, weekly, or hourly), employment status
(employed, terminated within the last 2 years, or terminated
more than 2 years prior, classified separately for risk
ages <62 years and 62 years) (20–22), and dose
(0,>0–<0.005, 0.005–<0.02, 0.02–<0.04, 0.04–<0.06, 0.06–
<0.08, 0.08–<0.1, 0.1–<0.125, 0.125–<0.150, 0.150–
<0.175, 0.175–<0.2, 0.2–<0.25, 0.25–<0.3, and 0.3 Sv).
Covariate control was achieved through background strat-
ification of regression models. In analyses of the LSS co-
hort, the stratifying factors were attained age, age at
exposure, and city; in analyses of the SRS cohort, the strat-
ifying factors were attained age, birth cohort, race, pay code,
and employment status. Radiation dose-mortality associa-
tions were estimated via a regression model of the form
rate ¼ eaið1 þ b xÞ;
where ai indexes the stratum-specific mortality rate in the
absence of radiation exposure and b̂ provides an estimate of
the excess relative rate (ERR) per sievert (23, 24).
In analyses of the LSS cohort, x represents the estimated
radiation dose delivered at the time of the bombings in
August 1945. Since follow-up of the LSS cohort began in
October 1950, this implies a minimal lag of approximately
5 years between exposure and its effect. We also present re-
sults from analyses in which we assumed that there was no
excess risk during the period 1950–1955; that is, a minimum
latency period of approximately 10 years was assumed. A
10-year lag assumption has been used in previous nuclear
worker studies that examined lymphoma mortality (25, 26).
We refer to analyses of LSS data that examine excess mor-
tality risk since 1950 and since 1956 as analyses carried out
under 5- and 10-year lag assumptions, respectively. In anal-
yses of the SRS cohort, x represents the cumulative radiation
dose under a 5- or 10-year lag assumption. Lagging dose
assignment by L years means that an increment of dose was
included in the calculation of cumulative dose at time t if it
had been received at or before time t  L years; person-time
and events at time t were then classified according to that
category of lagged cumulative dose.
The dose range in the LSS, 0–4 Sv, was wider than the dose
range in the SRS study (0–<0.5 Sv). In order to evaluate
dose-response associations over a comparable range of doses,
we also conducted analyses based upon LSS data limited to
the 19,183 survivors with doses in the range of 0–<0.5 Sv.
In analyses of the LSS cohort, we assessed variation in
radiation risk with time since exposure via a regression
model of the form
rate ¼ eaið1 þ b1xPeriod1 þ b2xPeriod2
þ b3xPeriod3 þ b4xPeriod4Þ;
where Period1–Period4 are indicator variables for the cal-
endar time periods 1950–1970, 1971–1980, 1981–1990, and
1991–2000, respectively. The values b̂1; b̂2; b̂3; and b̂4 pro-
vide estimates of the ERR per 1-Sv dose during the periods
5–25, 26–35, 36–45, and 46–55 years after the bombings. In
analyses of the SRS cohort, we fitted a model of the form
rate ¼ edið1 þ /1d1 þ /2d2 þ /3d3Þ;
where d1–d3 represent the cumulative radiation doses ac-
crued in the exposure time windows 5–25, 26–35, and
36 years prior to observation of a person-year or
event and /̂1; /̂2; and /̂3 provide associated estimates of
the ERR per 1-Sv dose.
We estimated parameters using the EPICURE statistical
package (Hirosoft International Corporation, Seattle,
Washington); for consistency with recent reports (2, 26),
we generated 90% confidence intervals for estimated param-
eters via the likelihood method (27). In some analyses, con-
fidence bounds could not be determined (designated ‘‘not
determined’’ (ND)). In order to aid interpretation of model
fittings, we report the 1-sided P value derived via a likeli-
hood ratio test (LRT) for each reported point estimate.
Tabulations of observed versus expected numbers of deaths
by category of cumulative dose are reported; we calculated
expected counts for each cell of the person-time table using
a regression model that included all variables except the
dose term.
RESULTS
With follow-up through 2000, 90 malignant lymphoma
deaths were observed among the male atomic bomb sur-
vivors exposed at ages 15–64 years, including 6 deaths from
Hodgkin’s disease (Table 1). Sixty-three malignant lym-
phoma deaths occurred among residents of Hiroshima (58
due to NHL) and 27 malignant lymphoma deaths occurred
among residents of Nagasaki (26 due to NHL). No deaths
due to malignant lymphoma occurred among survivors at
attained ages less than 30 years. In the SRS cohort, 56
lymphoma deaths were observed; 5 of these deaths were
due to Hodgkin’s disease. One death due to malignant lym-
phoma was observed among black males (it was a case of
NHL), and 18, 14, and 24 deaths due to malignant lym-
phoma were observed among workers paid monthly,
weekly, and hourly, respectively. Three deaths due to ma-
lignant lymphoma occurred among actively employed SRS
workers (all were cases of NHL) and 6 deaths occurred
within 2 years of termination of employment (all were cases
of NHL), while the remaining 47 deaths due to malignant
lymphoma occurred 2 or more years after termination of
employment at SRS (42 due to NHL).
In the LSS, the estimated ERR of malignant lymphoma
per sievert, under a 5-year lag assumption, was 0.79 (90%
confidence interval (CI): 0.10, 1.88). The goodness of model
fit was slightly improved, and the magnitude of association
was slightly increased, upon exclusion of deaths due to
Hodgkin’s disease (Table 2). Under a 10-year lag assump-
tion, these estimated associations were slightly larger in
magnitude. In the SRS study, the estimated ERRs of malig-
nant lymphoma per sievert under 5- and 10-year lag assump-
tions were 6.99 (90% CI: 0.96, 18.39) and 8.18 (90% CI:
1.44, 21.16), respectively. Upon exclusion of deaths due to
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Hodgkin’s disease, these estimated associations were
slightly smaller in magnitude. The SRS cohort included
a single death due to malignant lymphoma among black
workers; upon restriction to nonblack workers, the esti-
mated ERRs of malignant lymphoma per sievert under
5- and 10-year lag assumptions were 7.10 (90% CI: 1.00,
18.66) and 8.18 (90% CI: 1.44, 21.16), respectively.
When the LSS data were limited to survivors with doses
in the range of 0–<0.5 Sv, estimates of radiation-lymphoma
mortality associations were of greater magnitude than esti-
mates obtained from model fittings over the entire dose
range. Under a 5-year lag assumption, the estimated ERRs
of malignant lymphoma and NHL per sievert were 3.02
(90% CI: 0.33, 7.22) and 2.86 (90% CI: 0.10, 7.24), respec-
tively. While this suggests nonlinearity in the dose-response
association, comparison of a linear-quadratic dose-response
function with a purely linear dose-response function indi-
cated that inclusion of a quadratic term resulted in very little
improvement in model fit (LRT ¼ 0.07, 1 df; P ¼ 0.79).
Under a 10-year lag assumption, the estimated ERRs of
malignant lymphoma and NHL per sievert were 4.54
(90% CI: 1.16, 9.93) and 4.24 (90% CI: 0.83, 9.76),
respectively.
In the LSS, there was no evidence of an association be-
tween radiation dose and lymphoma mortality during the
periods 5–25 years or 26–35 years after irradiation (Table 3).
Positive associations between lymphoma mortality and
dose were observed during the periods 36–45 years and 46–
55 years after irradiation. Analyses of associations between
radiation dose and NHL led to risk estimates similar to those
obtained via analyses of all malignant lymphoma (Table 3).
In a nested model, defined post hoc, we evaluated the asso-
ciation between dose and malignant lymphoma mortality
during the periods 5–35 years postexposure and 36–55 years
postexposure. There was no evidence of association 5–35
years after exposure (ERR/Sv ¼ 0.03, 90% CI: ND, 1.15;
LRT ¼ 0.00, P ¼ 0.96); however, there was a positive
Table 2. Estimated Association Between Lymphoma Mortality and
Ionizing Radiation Dose Under 5- and 10-Year Exposure Lags
Among Male Atomic Bomb Survivors (1950–2000) and Male




















0.79 0.86 6.99 6.45
90% CI 0.10, 1.88 0.13, 2.03 0.96, 18.39 0.48, 17.95




1.06 1.12 8.18 7.62
90% CI 0.24, 2.38 0.26, 2.51 1.44, 21.16 0.93, 20.77
P value 0.02 0.02 0.03 0.05
Abbreviations: CI, confidence interval; ERR, excess relative rate.
a Japanese males who were aged 15–64 years and present in
Hiroshima or Nagasaki at the time of the bombings.
b P value from a likelihood ratio test that the reported parameter for
the estimated ERR was equal to 0.
Table 1. Observed Numbers of Deaths Due to Malignant Lymphoma Among Male Atomic
Bomb Survivors (1950–2000) and Male Workers at the Savannah River Site (1950–2002),





















<35 50,103 1 1 119,174 2 2
35–39 31,253 2 1 66,573 2 2
40–44 39,991 3 2 66,937 2 2
45–49 50,727 3 3 61,141 0 0
50–54 63,495 6 4 53,782 3 3
55–59 73,109 4 4 47,115 4 4
60–64 76,830 9 9 41,019 4 3
65–69 74,314 14 13 33,865 15 11
70–74 58,446 19 19 21,880 15 15
75–79 37,956 17 16 9,712 5 5
80 35,138 12 12 4,494 4 4
Total 591,359 90 84 525,691 56 51
a Because of rounding, column totals for person-time differ slightly from the sums of rows.
b Japanese males who were aged 15–64 years and present in Hiroshima or Nagasaki at the
time of the bombings.
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association between dose and lymphoma mortality 36
years after exposure (ERR/Sv ¼ 1.93, 90% CI: 0.48, 4.66;
LRT ¼ 6.83, P < 0.01).
In analyses of the SRS cohort, there was a highly impre-
cise positive association between lymphoma mortality and
doses accrued during the periods 5–25 and 26–35 years
prior. The association with doses accrued 36 years prior
was of the largest magnitude and contributed most to the
goodness of model fit. The estimated dose-response associ-
ation within each exposure time window was based on the
total number of lymphoma deaths. Similar estimates were
obtained in analyses restricted to NHL (Table 4).
When the LSS data were limited to those survivors with
doses in the range of 0–<0.5 Sv, there were positive, albeit
imprecise, estimates of association between radiation dose
and malignant lymphoma mortality during the periods 5–25
years after irradiation (ERR/Sv ¼ 0.64, 90% CI: 1.69,
5.94; LRT ¼ 0.1, P ¼ 0.75), 26–35 years after irradiation
(ERR/Sv ¼ 2.52, 90% CI: 1.48, 11.71; LRT ¼ 0.7, P ¼
0.40), 36–45 years (ERR/Sv ¼ 7.08, 90% CI: 0.08, 22.86;
LRT ¼ 2.6, P ¼ 0.11), and 46–55 years after irradiation
(ERR/Sv ¼ 6.42, 90% CI: 0.22, 23.11; LRT ¼ 2.4, P ¼
0.12). Results for analyses of NHL were similar to those for
all lymphoma mortality. There was a negative association
between radiation dose and NHL mortality during the period
5–25 years after irradiation (ERR/Sv ¼0.41, 90% CI: ND,
5.00; LRT ¼ 0.03, P ¼ 0.85) and positive associations be-
tween radiation dose and mortality during the periods 26–
35 years after irradiation (ERR/Sv ¼ 2.46, 90% CI: 1.50,
11.55; LRT ¼ 0.68, P ¼ 0.41), 36–45 years after irradia-
tion (ERR/Sv ¼ 7.07, 90% CI: 0.08, 22.83; LRT ¼ 2.61,
P ¼ 0.11), and 46–55 years after irradiation (ERR/Sv ¼
6.42, 90% CI: 0.23, 23.11; LRT ¼ 2.41, P ¼ 0.12).
Table 5 shows observed and expected numbers of malig-
nant lymphoma deaths by dose category under 5- and
10-year lag assumptions. The distribution of events among
SRS workers with respect to dose was relatively narrow in
comparison with the LSS data. Over the dose range at which
the ratio of observed to expected numbers of malignant
lymphoma deaths could be compared in these 2 cohorts
(i.e., 0–<0.5 Sv), these ratios were similar in magnitude
for analyses of the 2 cohorts, although values tended to be
slightly greater for the SRS cohort than for the LSS cohort.
Ratios of observed to expected numbers of deaths were
Table 3. Estimated Association Between Radiation Dose and Lymphoma Mortality Among















ERR per Sv 0.08 0.10 2.23 1.70
90% CI ND, ND ND, ND 0.09, 6.91 0.16, 5.36
P valueb 0.89 0.91 0.08 0.05
No. of deaths 31 20 16 23
Non-Hodgkin’s lymphoma
ERR per Sv 0.17 0.10 2.23 1.70
90% CI ND, ND ND, ND 0.09, 6.91 0.16, 5.36
P value 0.79 0.91 0.08 0.05
No. of deaths 25 20 16 23
Abbreviations: CI, confidence interval; ERR, excess relative rate; ND, not determined.
a Japanese males who were aged 15–64 years and present in Hiroshima or Nagasaki at the
time of the bombings.
b P value from a likelihood ratio test that the reported parameter for the estimated ERR was
equal to 0.
Table 4. Estimated Association Between Radiation Dose and
Lymphoma Mortality Among Male Workers at the Savannah River
Site, by Time Since Exposure, South Carolina, 1950–2002
Lymphoma Type
and ERR
Time Since Exposure, years
5–25 26–35 36–52
Malignant lymphoma
ERR per Sv 1.18 4.06 33.28
90% CI ND, ND ND, 25.34 4.83, 107.9
P valuea 0.85 0.64 0.03
Non-Hodgkin’s lymphoma
ERR per Sv 1.51 0.58 38.35
90% CI ND, 16.02 ND, 22.83 7.02, 121.57
P value 0.80 0.95 0.02
Abbreviations: CI, confidence interval; ERR, excess relative rate;
ND, not determined.
a P value from a likelihood ratio test that the reported parameter for
the estimated ERR was equal to 0.
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minimally affected by exclusion of deaths due to Hodgkin’s
disease (results not shown).
DISCUSSION
In a previous analysis of lymphoma mortality among sur-
vivors in the LSS, Pierce et al. (17) reported evidence of
a nonsignificant positive association with radiation dose
among males (ERR/Sv ¼ 0.27, 90% CI: ND, 1.49) and
a nonsignificant negative association among females
(ERR/Sv ¼ 0.17, 90% CI: ND, 0.30). In those analyses,
a time-constant ERR model was fitted to mortality follow-
up through 1990. In the present paper, time-window ana-
lyses helped to explain the observation of a significant positive
association between radiation dose and lymphoma mortality
among male atomic bomb survivors with more recent fol-
low-up, showing that positive associations have been ob-
served only since 1980. Such findings suggest a protracted
induction and latency period. If considered within the
framework of a multistage model of carcinogenesis, the
relatively long empirical induction period for lymphoma
following radiation exposure may be consistent with action
at an early stage of a multistage process.
The point estimates for the radiation dose-lymphoma
mortality association under 5- and 10-year lag assumptions
derived from analysis of the SRS cohort are larger than the
estimates derived from analysis of the LSS cohort (Table 2).
Differences in the magnitude and rate of exposure may in-
fluence the comparability of dose-response estimates. These
cohorts also differ with regard to potential biases from con-
founding, selection, and exposure measurement error. While
it is not an established cause of NHL, benzene is suspected
to be related to NHL (28). However, benzene was not used
in the production process at SRS, nor was it routinely used
as a degreaser. Plutonium-239 is a radiologic hazard at SRS.
While a recent study suggested that the contribution of plu-
tonium doses to total dose estimates for these workers was
relatively small (29), we did not directly assess confounding
by plutonium exposure. Selection bias could have influ-
enced these estimates of association—for example, via the
‘‘healthy worker’’ survivor effect (20). Although we ad-
justed for employment status, such an approach is sub-
optimal if employment status is an intermediate variable
Table 5. Observed and Expected Numbers of Deaths Due to Malignant Lymphoma Among Male Atomic Bomb
Survivors (1950–2000) and Male Workers at the Savannah River Site (1950–2002), by Radiation Dose, Japan and
South Carolinaa
Assumed Lag and Cohort
Radiation Dose, Sv
<0.005 0.005–<0.10 0.10–<0.20 0.20–<0.50 0.50–<1 1–<2 ‡2
5-year lag
Atomic bomb survivorsb
No. of deaths observed 32 29 8 11 3 5 2
Obs/Exp ratioc 0.80 0.97 1.33 1.61 0.72 2.04 2.60
Mean dose, Sv 0.001 0.032 0.141 0.322 0.721 1.340 2.392
Person-years of follow-up 260,641 195,354 38,255 45,932 28,566 16,674 5,937
Savannah River Site workers
No. of deaths observed 20 24 7 5 0 0 0
Obs/Exp ratio 0.77 1.01 1.78 2.14
Mean dose, Sv 0.001 0.028 0.142 0.266
Person-years of follow-up 305,131 181,767 25,961 12,830 0 0 0
10-year lag
Atomic bomb survivors
No. of deaths observed 27 27 8 11 3 5 2
Obs/Exp ratio 0.73 0.97 1.44 1.73 0.78 2.19 2.73
Mean dose, Sv 0.001 0.032 0.141 0.322 0.722 1.338 2.392
Person-years of follow-up 213,808 160,274 31,330 37,840 23,545 13,827 4,926
Savannah River Site workers
No. of deaths observed 21 24 6 5 0 0 0
Obs/Exp ratio 0.77 1.05 1.60 2.35
Mean dose, Sv 0.001 0.028 0.141 0.264
Person-years of follow-up 344,948 149,706 21,197 9,840 0 0 0
Abbreviations: Exp, expected; Obs, observed.
a Because of rounding, some column totals for person-time differ slightly from the sums of rows.
b Japanese males who were aged 15–64 years and present in Hiroshima or Nagasaki at the time of the bombings.
c Ratio of the number of deaths observed to the number of deaths expected.
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as well as a confounder of the association of interest. How-
ever, in studies of chronic diseases with long latency peri-
ods, cumulative exposure will typically not appreciably
influence employment termination rates; under such condi-
tions, employment status will play a minor role as an
intermediate variable but could have a strong role as a con-
founder of the association (22). Frequent reading of dosim-
eters could have led to dose underestimation if dosimeters
were not sufficiently exposed to reach a minimum detect-
able dose. However, prior work suggests that the impact of
this source of measurement error on estimates of radiation
dose-response trends is modest (30–32).
Problems of bias could also influence estimates of
radiation-mortality associations among atomic bomb survi-
vors. DS02 estimates account for the initial radiation
released from the detonation of the weapons but not radia-
tion from fallout or neutron activation of the ground and
structures (33). The available data suggest that most people
in Hiroshima and Nagasaki had low cumulative external
doses from fallout, with maximum estimates in the range
of 0.2–0.4 Sv for several hundred people who were in an
area of Nagasaki approximately 3 km from the hypocenter
(33, 34). Selective survival in the LSS cohort is another
concern and is a generic consideration when trying to un-
derstand the temporal evolution of exposure-related risk
(35). A relation between short-term survival after the bomb-
ings and later risk of lymphoma could lead to bias in
dose-response estimates. Evidence of selection has been
suggested by some empirical analyses (36, 37); however,
values for the magnitude of dose-related selective survival
assumed in a recent study suggested a modest potential for
bias in dose-response estimates (38).
These analyses provide evidence of a positive association
between ionizing radiation dose and malignant lymphoma
mortality among male Japanese atomic bomb survivors and
SRS workers. We did not address risk estimates for females,
for whom there was no evidence of a positive association
between radiation dose and lymphoma mortality in follow-
up through 1990 (17). The radiation-NHL mortality associ-
ations among these male atomic bomb survivors and SRS
workers are of larger magnitude than the estimate reported
in a 15-country study of nuclear workers (under a 10-year
lag assumption, ERR/Sv ¼ 0.44, 90% CI: <0, 4.78) (7);
however, in the current analyses, positive dose-response as-
sociations were primarily observed more than 35 years after
irradiation. These findings underscore the importance of
continued follow-up of the LSS cohort and nuclear worker
cohorts.
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